Rosa Fernández‐Torres

419 total citations
19 papers, 260 citations indexed

About

Rosa Fernández‐Torres is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Rosa Fernández‐Torres has authored 19 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Dermatology, 8 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Rosa Fernández‐Torres's work include Psoriasis: Treatment and Pathogenesis (8 papers), Dermatology and Skin Diseases (7 papers) and Autoimmune Bullous Skin Diseases (4 papers). Rosa Fernández‐Torres is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (8 papers), Dermatology and Skin Diseases (7 papers) and Autoimmune Bullous Skin Diseases (4 papers). Rosa Fernández‐Torres collaborates with scholars based in Spain. Rosa Fernández‐Torres's co-authors include Eduardo Fonseca, Sabela Paradela, Beatriz Fernández‐Jorge, Salvador Pita‐Fernández, Walter Martínez, Jesús del Pozo, Miguel Ángel Martínez‐González, Susana Castro, Roberto Martínez Álvarez and María Elena Mateos and has published in prestigious journals such as Value in Health, Dermatologic Surgery and Annals of Pharmacotherapy.

In The Last Decade

Rosa Fernández‐Torres

18 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Fernández‐Torres Spain 11 143 91 65 65 56 19 260
Claudia Lasagni Italy 12 170 1.2× 173 1.9× 61 0.9× 43 0.7× 28 0.5× 28 325
Khalad Maliyar Canada 9 185 1.3× 101 1.1× 22 0.3× 36 0.6× 41 0.7× 62 286
Shireen Sidhu Australia 10 128 0.9× 66 0.7× 15 0.2× 59 0.9× 52 0.9× 24 236
Z. Reguiaï France 10 303 2.1× 40 0.4× 170 2.6× 89 1.4× 26 0.5× 37 359
Kristina Hagenström Germany 9 135 0.9× 44 0.5× 74 1.1× 41 0.6× 12 0.2× 37 219
Karima Senouci Morocco 9 100 0.7× 26 0.3× 23 0.4× 66 1.0× 99 1.8× 131 295
Susumu Kitamura Japan 6 132 0.9× 146 1.6× 24 0.4× 17 0.3× 26 0.5× 6 220
Andrea Carugno Italy 7 105 0.7× 89 1.0× 19 0.3× 72 1.1× 45 0.8× 34 196
R.J.G. Chalmers United Kingdom 9 102 0.7× 59 0.6× 20 0.3× 54 0.8× 35 0.6× 18 187
Richuan Zheng Japan 8 198 1.4× 262 2.9× 19 0.3× 76 1.2× 69 1.2× 10 351

Countries citing papers authored by Rosa Fernández‐Torres

Since Specialization
Citations

This map shows the geographic impact of Rosa Fernández‐Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Fernández‐Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Fernández‐Torres more than expected).

Fields of papers citing papers by Rosa Fernández‐Torres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Fernández‐Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Fernández‐Torres. The network helps show where Rosa Fernández‐Torres may publish in the future.

Co-authorship network of co-authors of Rosa Fernández‐Torres

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Fernández‐Torres. A scholar is included among the top collaborators of Rosa Fernández‐Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Fernández‐Torres. Rosa Fernández‐Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Fernández‐Torres, Rosa, et al.. (2022). Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis. Frontiers in Medicine. 9. 1017323–1017323. 3 indexed citations
2.
Fernández‐Torres, Rosa, et al.. (2022). Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago. Dermatology and Therapy. 12(3). 761–770. 14 indexed citations
3.
Batalla, Ana, et al.. (2019). Escuela de dermatitis atópica: importancia de la formación de cuidadores. Piel. 34(7). 390–395. 2 indexed citations
4.
Salvador, Pilar, et al.. (2016). Positive correlation between etanercept concentration and the decrease in Psoriasis Area and Severity Index scale value. International Journal of Clinical Pharmacy. 38(5). 1142–1148. 8 indexed citations
5.
Fernández‐Torres, Rosa, Sabela Paradela, & Eduardo Fonseca. (2015). Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice. Value in Health. 18(8). 1158–1161. 10 indexed citations
6.
Paradela, Sabela, Rosa Fernández‐Torres, Walter Martínez, & Eduardo Fonseca. (2015). Teledermatology: diagnostic reliability in 383 children. European Journal of Dermatology. 25(6). 563–569. 19 indexed citations
7.
Paradela, Sabela, Rosa Fernández‐Torres, Walter Martínez, & Eduardo Fonseca. (2015). Apremilast en dermatología. Piel. 31(3). 206–215.
8.
Fernández‐Torres, Rosa, Salvador Pita‐Fernández, & Eduardo Fonseca. (2014). Quality of life and related factors in a cohort of plaque‐type psoriasis patients in La Coruña, Spain. International Journal of Dermatology. 53(11). e507–11. 23 indexed citations
9.
Fernández‐Torres, Rosa, et al.. (2014). Subcutaneous Histiocytoid Sweet Syndrome Associated with Crohn Disease in an Adolescent. Case Reports in Dermatological Medicine. 2014. 1–3. 12 indexed citations
10.
Fonseca, Eduardo, et al.. (2014). Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting. Journal of Dermatological Treatment. 26(3). 217–222. 14 indexed citations
11.
Paradela, Sabela, et al.. (2012). Long-term efficacy of infliximab in hidradenitis suppurativa. Journal of Dermatological Treatment. 23(4). 278–283. 38 indexed citations
12.
Fernández‐Torres, Rosa, Sabela Paradela, & Eduardo Fonseca. (2012). Long-term response to etanercept monotherapy in moderate to severe psoriasis: assessment in daily practice by the maintenance of low values of PASI and BSA. Journal of Dermatological Treatment. 25(1). 54–56. 19 indexed citations
13.
Fernández‐Torres, Rosa, et al.. (2010). Infliximab-Induced Lichen Planopilaris. Annals of Pharmacotherapy. 44(9). 1501–1503. 27 indexed citations
14.
Pozo, Jesús del, et al.. (2009). Venous malformations with lip involvement: Palliative treatment with carbon dioxide laser vaporization in five cases. Journal of Cosmetic and Laser Therapy. 11(1). 14–18. 7 indexed citations
15.
Pozo, Jesús del, et al.. (2008). Treatment of ulcerated haemangiomas with a non‐coherent pulsed light source: Brief initial clinical report. Journal of Cosmetic and Laser Therapy. 10(1). 48–51. 14 indexed citations
16.
Fernández‐Jorge, Beatriz, et al.. (2008). Concomitant allergic contact dermatitis from diphenhydramine and metronidazole. Contact Dermatitis. 59(2). 115–116. 8 indexed citations
17.
Martínez‐González, Miguel Ángel, Jesús del Pozo, Sabela Paradela, et al.. (2008). Bowen's disease treated by carbon dioxide laser. A series of 44 patients. Journal of Dermatological Treatment. 19(5). 293–299. 21 indexed citations
18.
Fernández‐Jorge, Beatriz, et al.. (2008). Shave and Phenolization of Periungual Fibromas, Koenenʼs Tumors, in a Patient with Tuberous Sclerosis. Dermatologic Surgery. 34(1). 111–113. 7 indexed citations
19.
Fernández‐Jorge, Beatriz, et al.. (2007). Shave and Phenolization of Periungual Fibromas, Koenen's Tumors, in a Patient with Tuberous Sclerosis. Dermatologic Surgery. 34(1). 111–113. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026